Abiomed Inc (ABMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

22 CHERRY HILL DR DANVERS, MA 01923

Abiomed is a publicly-traded medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump. The company is headquartered in Danvers, Massachusetts and has three additional offices, two in Germany in the cities of Berlin and Aachen, and another in Tokyo, Japan. Michael R. Minogue is Chairman, CEO & President of the company, with Dr. Thorsten Siess as Chief Technology Officer, Dr. Chuck Simonton as Chief Medical Officer and Dr. David M. Weber as Chief Operating Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients". As of 2019, the company had secured five FDA approvals and 715 patents with 622 pending. For fiscal year 2019, Abiomed reported $769.4 million in revenue and reported diluted earnings per share was $5.61 for the year. Abiomed was founded in Danvers, Massachusetts by David M. Lederman in 1981 as Applied Biomedical Corporation. That year, the company commenced the development of an artificial heart. Funded by federal research grants, Lederman partnered with The Texas Heart Institute to develop the AbioCor, a grapefruit-sized electromagnetic device with an internal battery that completely replaces the heart without wires or tubes passing through the skin. In July 2001, AbioCor became the first artificial heart successfully implanted in a patient, where it pumped more than 20 million times. Fourteen of the AbioCor devices were implanted, during clinical trials from 2001 to 2004, with the longest-living recipient surviving 512 days. The AbioCor won FDA approval in 2006 for patients who are near death and do not qualify for a heart transplant.

Data as of 2021-04-11 06:33:32 -0400
Market Cap15.099 Billion Shares Outstanding45.231 Million Avg 30-day Volume279.474 Thousand
P/E Ratio75.31688 Dividend Yield EPS4.39
Price/Sales18.57 Debt to Equity1.13 EBITDA248.08 Million
Price to Book Value11.97 Forward PE69.36 Enterprise Value14.612 Billion
Total Cash486.452 Million Current Debt120.4 Million Gross Profit657.738 Million
BETA0.93355 52-week High/Low387.4 / 152.21 Next Earnings Date2021-04-29 Price to Cash FLow (P/CF) 223.5328
Data provided by IEX Cloud
View SEC Filings from ABMD instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 8 5 60.0% 3 (0.18%) 2 (0.12%) 50.0%
Funds Holding: 479 484 -1.03% 87 (5.23%) 97 (6.04%) -10.31%
13F shares: 42.669 Million 42.346 Million 0.76% 10.714 Million 10.715 Million -0.01%
% Ownership 94.4222 93.7066 0.76% 23.7085 23.7108 -0.01%
New Positions: 61 78 -21.79% 10 17 -41.18%
Increased Positions 162 163 -0.61% 35 29 20.69%
Closed Positions 58 42 38.1% 20 17 17.65%
Reduced Positions 181 162 11.73% 31 39 -20.51%
Total Calls 700.541 Thousand 681.324 Thousand 2.82% 235.4 Thousand 268.9 Thousand -12.46%
Total Puts 713.318 Thousand 734.309 Thousand -2.86% 291.102 Thousand 282 Thousand 3.23%
PUT/CALL Ratio 1.02 1.08 -5.56% 1.24 1.05 18.1%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ABMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TRAPP TODD A VICE PRESIDENT, CFO

  • Officer
21,974 2021-04-09 3

GREENFIELD ANDREW J VP, CHIEF COMMERCIAL OFFICER

  • Officer
76,388 2021-03-31 8

MINOGUE MICHAEL R CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
778,616 2021-03-31 5

ROLLE MYRON L

  • Director
790 2021-02-17 2

SUTTER MARTIN P

  • Director
176,510 2021-02-16 7

PUHY DOROTHY E

  • Director
14,204 2021-02-01 5

BEGAN MARC A VP & GENERAL COUNSEL

  • Officer
4,471 2020-11-06 2

ROSE ERIC A MD

  • Director
14,475 2020-08-12 2

THOMAS PAUL

  • Director
7,191 2020-08-12 2

VAN GORDER CHRIS

  • Director
6,752 2020-08-12 2

RIVET JEANNINE M

  • Director
8,660 2020-08-12 1

WEBER DAVID M CHIEF OPERATING OFFICER

  • Officer
140,429 2020-05-29 2

HOWLEY MICHAEL G VP, GLOBAL SALES & MARKETING

  • Officer
51,365 2020-05-29 2

BOLT WILLIAM J SVP, QA AND REGULATORY AFFAIRS

  • Officer
61,381 2019-05-24 0

MCLEOD IAN VP, CORPORATE CONTROLLER

  • Officer
7,079 2018-02-28 0

TOMSICEK MICHAEL JOHN VICE PRESIDENT, CFO

  • Officer
27,081 2017-07-15 0

TERMEER HENRI A

  • Director
345,533 2016-08-09 0

AUSTEN W GERALD

  • Director
87,241 2015-08-12 0

BOWEN ROBERT CHIEF FINANCIAL OFFICER

  • Officer
76,265 2015-05-15 0

LATAIF LOUIS E

  • Director
111,175 2015-04-29 0

O CONNELL DESMOND JR

  • Director
67,062 2011-04-01 0

DOLLENS RONALD W

  • Director
5,839 2010-08-11 0

ABIOMED INC

  • Director
2,731,667 2008-12-16 0

SUTHERBY DANIEL J CFO, CAO

  • Officer
43,354 2008-09-16 0

FITCH PATRICIA A. VICE PRESIDENT OF SALES

  • Officer
5,000 2008-05-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TRAPP TODD A - Officer VICE PRESIDENT, CFO

2021-04-13 17:14:30 -0400 2021-04-09 F 936 $329.75 d 8,444 direct 2.1143 2.1143 2 0.0 1

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2021-04-02 16:25:18 -0400 2021-03-31 A 52 a 210,853 direct 0.6594 3.6112 3.8289 5 -0.2737 3

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2021-04-02 16:31:29 -0400 2021-03-31 A 30 a 36,960 direct 0.6594 3.6112 3.8289 5 -0.2737 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ABIOMED INC ABMD 2021-04-19 22:15:03 UTC -0.2444 0.3044 750000
ABIOMED INC ABMD 2021-04-19 21:45:03 UTC -0.2444 0.3044 750000
ABIOMED INC ABMD 2021-04-19 21:15:03 UTC -0.2444 0.3044 750000
ABIOMED INC ABMD 2021-04-19 20:45:03 UTC -0.2598 0.3198 750000
ABIOMED INC ABMD 2021-04-19 20:15:05 UTC -0.2598 0.3198 750000
ABIOMED INC ABMD 2021-04-19 19:45:03 UTC -0.2598 0.3198 750000
ABIOMED INC ABMD 2021-04-19 19:15:02 UTC -0.2598 0.3198 750000
ABIOMED INC ABMD 2021-04-19 18:45:03 UTC -0.26 0.32 750000
ABIOMED INC ABMD 2021-04-19 18:15:03 UTC -0.26 0.32 750000
ABIOMED INC ABMD 2021-04-19 17:45:03 UTC -0.26 0.32 750000
ABIOMED INC ABMD 2021-04-19 17:15:13 UTC -0.26 0.32 750000
ABIOMED INC ABMD 2021-04-19 16:45:02 UTC -0.19 0.25 750000
ABIOMED INC ABMD 2021-04-19 16:15:03 UTC -0.19 0.25 750000
ABIOMED INC ABMD 2021-04-19 15:45:03 UTC -0.19 0.25 750000
ABIOMED INC ABMD 2021-04-19 15:15:03 UTC -0.19 0.25 750000
ABIOMED INC ABMD 2021-04-19 14:45:03 UTC -0.1969 0.2569 750000
ABIOMED INC ABMD 2021-04-19 14:15:03 UTC -0.1969 0.2569 750000
ABIOMED INC ABMD 2021-04-19 13:45:02 UTC -0.1969 0.2569 750000
ABIOMED INC ABMD 2021-04-19 13:15:02 UTC -0.1969 0.2569 750000
ABIOMED INC ABMD 2021-04-19 12:45:03 UTC -0.1969 0.2569 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund ABMD -10.0 shares, $-2770.6 2020-09-30 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund ABMD 1537.0 shares, $-421291.7 2020-11-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund ABMD -120.0 shares, $-38904.0 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund ABMD -11.0 shares, $-3566.2 2020-12-31 N-PORT
FundVantage Trust- Gotham Absolute 500 Core Fund ABMD -12.0 shares, $-1741.92 2020-03-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund ABMD -52.0 shares, $-16858.4 2020-12-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ABMD -192.0 shares, $-62246.4 2020-12-31 N-PORT

Elevate your investments